SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oxford GlycoSciences Plc
An SI Board Since January 2000
Posts SubjectMarks Bans
469 13 0
Emcee:  Jongmans Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
294United States Patent Application 20020191825 Kind Code A1 Parekh, Rajesh Bhscaram(o)uche-12/28/2002
293Foreign Application Priority Data......... Nov 29, 1996[GB] patft.uspto.gov; scaram(o)uche-12/28/2002
292patft.uspto.gov; We claim: 1. A computer-controlled device for removing a selscaram(o)uche-12/28/2002
291<i>A number of companies are using technology that's probably in violascaram(o)uche-12/28/2002
290dated the day before the bail......... yahoo.businessweek.com From Proteins toscaram(o)uche-12/28/2002
289>> If the company decides to pull the plug on the US adr, the US holder liscaram(o)uche-12/28/2002
288>>what does it take to create an ADR? Is there a process to convert non-ADkeokalani'nui-12/28/2002
287>> Don't forget it trades in the UK too. << My point was that iscaram(o)uche-12/28/2002
286Don't forget it trades in the UK too. :-) uk.finance.yahoo.comnigel bates-12/28/2002
285Chuckle.... quick, before it changes..... look at the scale for the volume, scaram(o)uche-12/27/2002
284>> Once distributed, then......? << $627.00, give or take a little.scaram(o)uche-12/27/2002
283Enormous seller (given the ever-lasting liquidity issue), out of the blue. Openscaram(o)uche-12/27/2002
282Thanks for the research! You clarified it, big-time. Looks like, if they hit iscaram(o)uche-12/27/2002
281The SGP equity investment was $5m; research funding about $4m per year (from thenigel bates-12/27/2002
280One of the classic means to launder your trade...... b-trade.comscaram(o)uche-12/27/2002
279Seems to be plenty available at $2.35 (whoever btrd is). Once distributed, thenkeokalani'nui-12/27/2002
278Useful site: oanda.comkeokalani'nui-12/27/2002
277The company seems to keep cash rolling in, and now they've started to hit miscaram(o)uche-12/27/2002
276Wow, thanks!! Yeah, but that's in those poundie things. How much is it in scaram(o)uche-12/27/2002
275Reformat <g> <pre>5. Other investments nigel bates-12/27/2002
274H&Q, Bear Stearns and SG Cowen were trying to get them out the door one yearscaram(o)uche-12/27/2002
273from 6-K, 1 October 2002....... 5. Other investments BioInvent scaram(o)uche-12/27/2002
272The next time any of our Boston-centered biofreaks are in Cambridge? Could you scaram(o)uche-12/27/2002
271J Biol Chem 2002 Dec 10; [epub ahead of print] Comprehensive proteomic analysisscaram(o)uche-12/27/2002
270Parking: >>Proc Natl Acad Sci U S A 2002 Nov 26;99(24):15428-33 Chemicatuck-12/21/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):